Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiba
about
sameAs
Management of patients with unstable angina / non-ST-elevation myocardial infarction: a critical review of the 2007 ACC /AHA guidelinesEfficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysisEnoxaparin injection for the treatment of high-risk patients with non-ST elevation acute coronary syndromePharmacological and clinical differences between low-molecular-weight heparins: implications for prescribing practice and therapeutic interchange.Bleeding risk during treatment of acute thrombotic events with subcutaneous LMWH compared to intravenous unfractionated heparin; a systematic review.Emergency cardiac surgery in patients with acute coronary syndromes: a review of the evidence and perioperative implications of medical and mechanical therapeutics.Low-molecular-weight heparins in the cardiac catheterization laboratoryThe impact of bleeding in patients with acute coronary syndromes: how to optimize the benefits of treatment and minimize the risk.The decline effect in cardiovascular medicine: is the effect of cardiovascular medicine and stent on cardiovascular events decline over the years?Anti-Xa activity of enoxaparin and nadroparin in patients with acute coronary syndrome.
P2860
Q24653318-C1BE9AA1-1DAB-479D-B801-ABDD43E3FA87Q26853150-445D9E75-DFFA-4E25-ACF0-9E462165C4D4Q28213718-D92F6E83-4745-4F63-9821-684B35450913Q33685447-0CAF1E10-BB1F-4582-BD56-F3F3D6546157Q34415964-306586AB-7C39-45B9-BAB3-C4D87F1B5A7EQ34716730-1051277F-2B68-4749-A85E-55FD4F75A7BDQ35733959-25559479-9CD2-4098-B0BB-44EF2DDDF824Q36861495-3E991D3D-3EDE-4FD0-96EC-94F4D7A9D737Q37098181-A46B5203-BCE9-490B-8702-9413E270E49FQ41807158-DFBC66AA-97F9-4288-95FF-F864534CEDCD
P2860
Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiba
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Randomized double-blind safety ...... tic Combination Using Tirofiba
@en
Randomized double-blind safety ...... tic Combination Using Tirofiba
@nl
type
label
Randomized double-blind safety ...... tic Combination Using Tirofiba
@en
Randomized double-blind safety ...... tic Combination Using Tirofiba
@nl
prefLabel
Randomized double-blind safety ...... tic Combination Using Tirofiba
@en
Randomized double-blind safety ...... tic Combination Using Tirofiba
@nl
P2093
P356
P1476
Randomized double-blind safety ...... Using Tirofiban and Enoxaparin
@en
P2093
ACUTE II Investigators
Fred Senatore
Frederique Bigonzi
Harvey D White
Kathy Harris
Marc Cohen
Martin J Frey
Pierre Théroux
Robin Mukherjee
P304
P356
10.1067/MHJ.2002.126115
P407
P577
2002-09-01T00:00:00Z